Ppk Group Limited · ASX:PPK

Ppk — Shareholder Meeting (November 2022)

20 slides from Ppk's shareholder meeting presentation, Nov 23, 2022

  1. Slide 1: Chief Operating Officer's Presentation

    ASX ANNOUNCEMENT FOR IMMEDIATE RELEASE TO THE MARKET PPK GROUP LIMITED – ASX Code: PPK Wednesday 23 November 2022 Chief Operating Officer’s Presentation PPK Group Limited (ASX Code: PPK) is pleased to provide the Chief Operating Officer’s presentation, which will be presented at the Company’s Annual

  2. Slide 2: Annual General Meeting

    ANNUAL GENERAL MEETING Wednesday, 23 November 2022 PPK AGM 23 November 2022 1

  3. Slide 3: Chairman's Address

    CHAIRMAN’S ADDRESS Wednesday, 23 November 2022 PPK AGM 23 November 2022

  4. Slide 4: Introducing the PPK board

    Introducing the PPK board Robin Levison Glenn Molloy Anne-Marie Birkill Anthony McDonald Non-Executive Chairman Executive Director Non-Executive Director Non-Executive Director PPK AGM 23 November 2022 3

  5. Slide 5: Chairman's address

    Chairman’s address • New team • Commercialise our technologies, with BNNT and White Graphene the priority • Mining divestment • Funding for current scope • Market conditions PPK AGM 23 November 2022 4

  6. Slide 6: Presentation by the Chief Operating Officer

    PRESENTATION BY THE CHIEF OPERATING OFFICER Wednesday, 23 November 2022 PPK AGM 23 November 2022

  7. Slide 7: How we work to deliver shareholder value

    How we work to deliver shareholder value Find, discover, identify, assess Realise and Science / monetise 3rd Party Market, risk capital Value creation Model, governance, key roles Opportunity to Corporatise commercialise Commit PPK AGM 23 November 2022 6

  8. Slide 8: Proving the science update

    Legend Proving the science update Paused Closed 3D Dental 45% R&D • Nature of science - not all will Ballistic Glass 40% succeed • Continuous learning – new Realise and Science / monetise 3rd Party derivatives arise • Stage gate approach Value creation Opportunity to Corporatise commercialise Strate

  9. Slide 9: PPK Investee Companies Pathways to Profit

    PPK Investee Companies Pathways to Profit • We are confident to sell and produce • Applications for WGL and BNNT Realise and Science/ monetise 3rd Party • We have lowered cost of BNNT Value creation production and can produce at scale Corporatise Opportunity to and quality commercialise PPK AGM 23 N

  10. Slide 10: Value creation alternatives

    Value creation alternatives Revenues and IPO Partial or full disposal of an profits from investee company subsidiaries Example: Future potential: PPK AGM 23 November 2022 9

  11. Slide 11: Key learnings applied to commercialisation setup

    Key learnings applied to commercialisation Understand Simplified Agreed Collaboration partner collaboration and schedule and through the process and material transfer milestones process setup – go agreements see Done well will lead to … Product market fit and commercialisation PPK AGM 23 November 20

  12. Slide 12: White Graphene raised $3.6m capital to continue expansion plans

    White Graphene raised $3.6m capital to continue expansion plans • Increasing factory size and production output in Geelong facility • Scientific results published in March and August 2022 on addition of White Graphene to commercial coatings led to significant market interest • Currently working with

  13. Slide 13: BNNT focus is on commercialisation and optimised production in the new facility

    BNNT focus is on commercialisation and optimised production in the new facility • New factory operational • Increase automation • Lowered cost of production • Collaboration and product testing with potential partners and customers • Commercial role PPK AGM 23 November 2022 12

  14. Slide 14: Li-S Energy market opportunity

    Li-S Energy market opportunity PASSENGER EVs DRONES HEAVY EVs eAVIATION PPK AGM 23 November 2022 13

  15. Slide 15: Cell scale up process

    Phase 3 is essential for delivering quality test cells for Cell scale up process our partners — with each trial requiring up to 10,000 cells PHASE 1 PHASE 2 PHASE 3 Proving the science Scaling cell size Scaling output to meet demand coin cell single layer pouch 4-layer pouch 10-layer pouch 20-layer

  16. Slide 16: Deakin University drone flight

    DRONE FLIGHT Deakin University 15

  17. Slide 17: AMAG has significant global interest and just raised $3m capital

    AMAG has significant global interest and just raised $3m capital • Strong pipeline • $3m capital raise to support the expansion of the company’s operations in North America and establish itself as a market leader in the global transport analytics industry • Key international appointment PPK AGM 23 N

  18. Slide 18: CIB continues to deliver

    CIB continues to deliver • Revenues $15.9M • Pre-tax profit, before management fees $3.0M • Order book continues to grow • Aerospace autoclave commissioned, one of the largest in Australia, positioned for larger defence contracts • Hydraulic press ordered; will be largest in southern hemisphere for

  19. Slide 19: In closing

    In closing Collaboration and Addressable market Nothing will please PPK and product testing will lead remains significant us more than investee to commercialisation as across all investee standing here again companies we know we can companies – we can next year with funded for manufacture at a price

  20. Slide 20: Conclusion of the meeting

    CONCLUSION OF THE MEETING RESULTS OF MEETING TO BE ANNOUNCED TO THE ASX SHORTLY

PPK Group — Shareholder Meeting (November 2022) on 6ix